Trial Outcomes & Findings for The Impact of Qualia Vitamin C+ on Blood Vitamin C Levels (NCT NCT07285109)

Results Overview

To assess between-group differences in the change in blood Vitamin C levels from baseline to Day 28 following supplementation with Qualia Vitamin C+ versus placebo.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

36 participants

Primary outcome timeframe

0-28 days

Results posted on

2026-05-07

Participant Flow

Participant milestones

Participant milestones
Measure	Qualia Vitamin c+ Qualia Vitamin C+ manufactured by Qualia Life Sciences	Placebo Rice flour placebo
Overall Study STARTED	19	17
Overall Study COMPLETED	18	17
Overall Study NOT COMPLETED	1	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Qualia Vitamin c+ n=19 Participants Qualia Vitamin C+ manufactured by Qualia Life Sciences	Placebo n=17 Participants Rice flour placebo	Total n=36 Participants Total of all reporting groups
Age, Categorical <=18 years	0 Participants n=19 Participants	0 Participants n=17 Participants	0 Participants n=36 Participants
Age, Categorical Between 18 and 65 years	18 Participants n=19 Participants	17 Participants n=17 Participants	35 Participants n=36 Participants
Age, Categorical >=65 years	1 Participants n=19 Participants	0 Participants n=17 Participants	1 Participants n=36 Participants
Sex: Female, Male Female	10 Participants n=19 Participants	8 Participants n=17 Participants	18 Participants n=36 Participants
Sex: Female, Male Male	9 Participants n=19 Participants	9 Participants n=17 Participants	18 Participants n=36 Participants
Race and Ethnicity Not Collected	—	—	0 Participants Race and Ethnicity were not collected from any participant.

PRIMARY outcome

Timeframe: 0-28 days

Population: Per protocol population: participants who completed blood vitamin C level testing at baseline and Day 28 and took study products on at least 80% of days

To assess between-group differences in the change in blood Vitamin C levels from baseline to Day 28 following supplementation with Qualia Vitamin C+ versus placebo.

Outcome measures

Outcome measures
Measure	Qualia Vitamin c+ n=17 Participants Qualia Vitamin C+ manufactured by Qualia Life Sciences	Placebo n=15 Participants Rice flour placebo
To Assess Between-group Differences in the Change in Blood Vitamin C Levels From Baseline to Day 28	0.365 mg/dL Standard Deviation 0.483	0.133 mg/dL Standard Deviation 0.213

Adverse Events

Qualia Vitamin c+

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Placebo

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Director of Research

Qualia Life Sciences

Phone: (855) 281-2328

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place